MYLAN 8030 MYLAN 8030 (Lansoprazole delayed release 30 mg)

Pill imprint MYLAN 8030 MYLAN 8030 has been identified as Lansoprazole delayed release 30 mg.

Lansoprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; helicobacter pylori infection; gastritis/duodenitis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lansoprazole delayed release

Imprint:

MYLAN 8030 MYLAN 8030

Strength:

30 mg

Color:

Pink

Shape:

Capsule-shape

Availability:

Rx and/or OTC

Drug Class:

Proton pump inhibitors

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-8030

Inactive Ingredients:

silicon dioxide
corn starch
hydroxypropyl cellulose
low substituted hydroxypropyl cellulose
magnesium carbonate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol
polysorbate 80
sucrose
magnesium silicate
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 3
gelatin
propylene glycol
shellac
ferrosoferric oxide
potassium hydroxide

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
51079-0121	UDL Laboratories Inc

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.